Assenagon Asset Management S.A. Has $2.44 Million Stock Position in Balchem Co. (NASDAQ:BCPC)

Assenagon Asset Management S.A. cut its holdings in Balchem Co. (NASDAQ:BCPC) by 85.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,961 shares of the basic materials company’s stock after selling 88,050 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Balchem were worth $2,439,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Westside Investment Management Inc. acquired a new position in shares of Balchem during the 3rd quarter valued at $27,000. nVerses Capital LLC acquired a new position in shares of Balchem during the third quarter valued at about $35,000. Wilmington Savings Fund Society FSB bought a new position in shares of Balchem during the 3rd quarter worth about $35,000. Blue Trust Inc. grew its stake in shares of Balchem by 642.5% in the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after buying an additional 726 shares during the period. Finally, GAMMA Investing LLC increased its position in Balchem by 73.4% in the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after buying an additional 356 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. HC Wainwright increased their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Stock Down 0.6 %

Shares of NASDAQ BCPC opened at $162.10 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company has a 50-day moving average price of $169.56 and a 200-day moving average price of $170.89. The stock has a market capitalization of $5.27 billion, a P/E ratio of 43.58, a P/E/G ratio of 4.31 and a beta of 0.69. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03.

Balchem Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. The ex-dividend date was Thursday, December 26th. This represents a yield of 0.4%. This is an increase from Balchem’s previous annual dividend of $0.79. Balchem’s payout ratio is 23.39%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.